| 中文名称 | 蜕皮激素 |
|---|---|
| 中文别名 | 蜕皮激素;蜕皮甾酮;Α-蜕化激素;Α-蜕皮激素;Α-蜕皮甾酮(2Β,3Β,5Β,22R)-2,3,14,22,25-五羟基胆甾醇-7烯-6酮;(2Β,3Β,5Β,22R)-2,3,4,20,22,25-六羟基胆甾醇-7-烯-6-酮;20-羟基蜕化素;Β-蜕化激素;Β-蜕皮激素;Β-蜕皮甾酮;蜕皮松;(2B,3B,5B,22R)-2,3,14,22,25-五羟基胆甾-7-烯-6-酮;蜕化素;beta-蜕皮甾酮;阿尔法-蜕皮激素;绞股蓝皂苷;alpha-蜕皮激素;α-蜕皮素 |
| 英文名称 | Ecdysone |
| 英文别名 | 2BETA,3BETA,14ALPHA,22[R],25-PENTAHYDROXY-7-CHOLESTEN-6-ONE;7,(5-ALPHA)-CHOLESTEN-2-BETA, 3-BETA, 14-ALPHA, 22R, 25-PENTOL-6-ONE;ALPHA-ECDYSON;ALPHA-ECDYSONE;ALPHA-ECDYSTERONE;ECDYSONE;ECDYSONE, ALPHA-;2,3,14,22,25-pentahydroxy-,(2-beta,3-beta,5-beta,22r)-cholest-7-en-6-on;2-beta,3-beta,14,22,25-pentahydroxy-,(20s,22r)-5-beta-cholest-7-en-6-on;(2beta,3beta,5beta,22R)-2,3,14,22,25-pentahydroxycholest-7-en-6-one;2β,3β,14α,22(r),25-pentahydroxy-7-cholesten-6-one;ALPHA-ECYSONE;β-Ecdysone[20-Hydroxyecdysone];A-ECDYSONE;(2b,3b,5b,22R)-2,3,14,22,25-Pentahydroxycholest-7-en-6-one;ECDYSONE, ALPHA-(RG);α-Ecdysone;(2β,3β,5β,22R)-2,3,14,22,25-pentahydroxycholest-7-en-6-one;[3H]-Ecdysone;Gynostemma Gypenosides;SR-05000002190;Cholest-7-en-6-one, 2,3,14,22,25-pentahydroxy-, (2b,3b,5b,22R)-;Cholest-7-en-6-one, 2,3,14,22,25-pentahydroxy-, (2-beta,3-beta,5-beta,22R)-;2beta,3beta,14alpha,22(R),25-Pentahydroxy-7-cholesten-6-one;RH692X7B7B;UNII-RH692X7B7B;EINECS 222-760-4;ECDYSONE, .ALPHA.-;BRN 2422986;3604-87-3;BCBcMAP01_000123;NS00029970;(22R)-2beta,3beta,14,22,25-pentahydroxy-5beta-cholest-7-en-6-one;HY-N0179;(2S,3R,5R,9R,10R,13R,14S,17R)-17-[(2S,3R)-3,6-dihydroxy-6-methylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one;alpha-Ecdysone, >=90%;CHEMBL549300;SCHEMBL23780;CCG-208571;SMP1_000109;(22R)-2beta,3beta,14alpha,22,25-pentahydroxy-5beta-cholest-7-en-6-one;CHEBI:16688;ECDYSONE [MI];2beta,3beta,14alpha,22R,25-pentahydroxy-5beta-cholest-7-en-6-one;7, (5alpha)-Cholesten-2beta, 3beta, 14alpha, 22r, 25-pentol-6-one;(2S,3R,5R,9R,10R,13R,14S,17R)-17-((2S,3R)-3,6-dihydroxy-6-methylheptan-2-yl)-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6(10H)-one;(2.BETA.,3.BETA.,5.BETA.,22R)-2,3,14,22,25-PENTAHYDROXYCHOLEST-7-EN-6-ONE;C00477;SR-05000002190-3;Cholest-7-en-6-one, 2,3,14,22,25-pentahydroxy-, (2beta,3beta,5beta,22R)-;Cholest-7-en-6-one, 2,3,14,22,25-pentahydroxy-, (2.beta.,3.beta.,5.beta.,22R)-;alpha-Ecdysone, >=99.0% (UV);-Ecdysone;LMST01010210;4-08-00-03613 (Beilstein Handbook Reference);MFCD00042683;CS-0007889;AI3-44726;Alpha-Ecdysone ( >90%);Q139085;.ALPHA.-ECDYSONE;CCRIS 6931;AKOS015951280;5-beta-Cholest-7-en-6-one, 2-beta,3-beta,14,22,25-pentahydroxy-, (20S,22R)-;HB3881;DTXSID2020553;(22R)-2b,3b,14,22,25-Pentahydroxy-5b-cholest-7-en-6-one;(2ss,3ss,5ss,22R)-2,3,14,22,25-pentahydroxycholest-7-en-6-one;G12108;DTXCID40553;(2S,3R,5R,9R,10R,13R,14S,17R)-17-((2S,3R)-3,6-dihydroxy-6-methylheptan-2-yl)-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta(a)phenanthren-6-one;(22R)-2b,3b,14a,22,25-Pentahydroxy-5b-cholest-7-en-6-one;Cholest-7-en-6-one, 2,3,14,22,25-pentahydroxy-, (2-beta,3-beta,5-beta,22R)-(9CI);a-Ecdysone ( >90%) |
| CAS No. | 3604-87-3 |
| 分子式 | C27H44O6 |
| 分子量 | 464.63 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学